Previous Article | Next Article ![]()
Antimicrobial Agents and Chemotherapy, December 2005, p. 5182-5184, Vol. 49, No. 12
0066-4804/05/$08.00+0 doi:10.1128/AAC.49.12.5182-5184.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.
Department of Pathology, Hershey Medical Center, Hershey, Pennsylvania 17033
Received 19 July 2005/ Returned for modification 12 September 2005/ Accepted 23 September 2005
Against 307 pneumococci of various resistotypes, dalbavancin MICs were 0.008 to 0.125 µg/ml. All strains were susceptible to vancomycin, teicoplanin, linezolid, and quinupristin-dalfopristin. Dalbavancin at 2x MIC was bactericidal against all 10 pneumococci tested after 24 h. Vancomycin and teicoplanin killed 10 and 8 strains, respectively, at 2x MIC after 24 h.
This article has been cited by other articles:
| Clin. Vaccine Immunol. | Clin. Microbiol. Rev. |
|---|---|
| J. Clin. Microbiol. | ALL ASM JOURNALS |